Sign in

CIK 0001297184 · Large accelerated filer

Amphastar Pharmaceuticals, Inc.

Sign in to watch
Ticker
AMPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
330702205
Phone
909-980-9484
Business address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
  1. 4 Open-market sale EVP, QA & Regulatory Affairs sold 1,427 shares at $13.97 ($19,939)
  2. 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,383 shares (to pay taxes)
  3. 4 Open-market sale EVP, QA & Regulatory Affairs sold 21,244 shares at an average $12.89 ($273,774)
  4. 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 741 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP, Production gave up 568 shares (to pay taxes)
  6. 4 Shares withheld for taxes EVP, QA & Regulatory Affairs gave up 614 shares (to pay taxes)
  7. 4 Shares withheld for taxes CFO, SVP & Treasurer gave up 1,823 shares (to pay taxes)
  8. 4 Shares withheld for taxes President gave up 10,652 shares (to pay taxes)
  9. 4 Shares withheld for taxes CEO & Chief Science Officer gave up 56,912 shares (to pay taxes)
  10. 4 Open-market sale Director sold 2,400 shares at $11.25 ($27,000)
  11. 4 Grant or award EVP, QA & Regulatory Affairs acquired 11,253 shares (grant or award)
  12. 4 Grant or award EVP, Production acquired 11,473 shares (grant or award)
  13. 4 Grant or award CFO, SVP & Treasurer acquired 39,717 shares (grant or award)
  14. 4 Grant or award President acquired 75,022 shares (grant or award)
  15. 4 Grant or award CEO & Chief Science Officer acquired 263,901 shares (grant or award)
  16. 4 Gift Director gave 350 shares (gift)
  17. 3/A Insider 3/A
  18. 4/A Insider Changes in Ownership
  19. 4/A Open-market sale CEO & Chief Science Officer sold 160,495 shares at an average $16.23 ($2,605,207)
  20. 4 Open-market sale EVP, Production sold 772 shares at $14.29 ($11,032)

Page 27 of 31 · 601 filings